Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JUNO | AMGN | VRTX | REGN | GILD |
| Company | Juno Therapeutics | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 86.97 | 335.99 | 494.00 | 1,070.75 | 74.75 |
| High | 87.01 | 346.85 | 503.99 | 1,102.95 | 77.34 |
| Low | 86.90 | 333.02 | 490.70 | 1,061.72 | 74.38 |
| Last | 86.96 | 334.30 | 492.26 | 1,064.19 | 76.51 |
| Change | +0.09 | -1.31 | +1.46 | +3.33 | +3.01 |
| % Change | +0.10% | -0.39% | +0.30% | +0.31% | +4.10% |
| Volume | 3,696,100 | 2,435,700 | 990,400 | 528,300 | 11,733,301 |
| 20-Day Average Volume | 4,145,455 | 1,925,500 | 1,095,715 | 411,940 | 6,392,480 |
| Previous Close | 86.87 | 335.61 | 490.80 | 1,060.86 | 73.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 86.09 | 323.67 | 484.43 | 1,063.18 | 70.36 |
| 20-Day Raw Stochastic | 97.77% | 69.19% | 69.12% | 55.58% | 92.67% |
| 20-Day Relative Strength | 73.72% | 65.25% | 63.47% | 55.85% | 69.10% |
| Weighted Alpha | +175.90 | +41.11 | +42.86 | +41.31 | +2.67 |
| Today's Opinion | N/A | 100% Buy | 100% Buy | 100% Buy | 24% Buy |
| Previous Opinion | N/A | 100% Buy | 100% Buy | 88% Buy | 24% Buy |
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | 100% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.42% since 02/26/18 | +1.01% since 07/18/24 | +0.85% since 07/18/24 | -0.29% since 07/18/24 | +4.08% since 07/18/24 |
| Low | 86.60 on 02/27/18 | 328.43 on 07/19/24 | 486.25 on 07/24/24 | 1,052.81 on 07/24/24 | 70.78 on 07/23/24 |
| High | 87.01 on 03/05/18 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,102.95 on 07/25/24 | 77.34 on 07/25/24 |
| 1-Month | |||||
| %Chg | +1.57% since 02/05/18 | +4.69% since 06/25/24 | +3.89% since 06/25/24 | -0.65% since 06/25/24 | +9.91% since 06/25/24 |
| Low | 84.77 on 02/20/18 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 87.01 on 03/05/18 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,106.16 on 07/12/24 | 77.34 on 07/25/24 |
| 3-Month | |||||
| %Chg | +63.46% since 12/05/17 | +24.10% since 04/25/24 | +23.78% since 04/25/24 | +19.48% since 04/25/24 | +17.22% since 04/25/24 |
| Low | 42.29 on 12/19/17 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 87.01 on 03/05/18 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,106.16 on 07/12/24 | 77.34 on 07/25/24 |
| 6-Month | |||||
| %Chg | +103.75% since 09/05/17 | +7.75% since 01/25/24 | +14.49% since 01/25/24 | +12.15% since 01/25/24 | -4.64% since 01/25/24 |
| Low | 40.11 on 09/06/17 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 87.01 on 03/05/18 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,106.16 on 07/12/24 | 80.51 on 01/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,096,926 | 179,330,224 | 127,029,184 | 117,258,816 | 95,320,224 |
| Shares Outstanding, K | 116,110 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 79,360,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -245,580,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 44,820,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -118,130,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 3.24 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 11/01/17 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 03/07/18 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.01 | 32.59 | 28.59 | 18.24 |